Cognetivity Neurosciences Ltd.

Recent News

• Cognetivity Neurosciences Unveils Groundbreaking Research on Cognition and Sleep, Extends Collaboration with University of Oxford

  Vancouver, British Columbia--(Newsfile Corp. - March 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce important validation results for the use of its CognICA technology in measuring the impact of changes in sleep patterns on brain health, as well as further collaboration with Oxford University to detect the earliest signs of...

  2023-03-23 9:29 AM EDT
• Cognetivity Neurosciences Enters Commercial Agreement with UK-Based Brain Health Supplements Provider

  Vancouver, British Columbia--(Newsfile Corp. - March 15, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that it has reached a commercial agreement with brain health supplements provider Conka.Conka is a UK-based provider of natural brain health supplements, geared towards individuals engaging in high-performance sports and other physical activities. Conka's mission is...

  2023-03-15 9:30 AM EDT
• Cognetivity Neurosciences Publishes Outstanding Results and Expands Deployment With Senior Care Network in Singapore

  Vancouver, British Columbia--(Newsfile Corp. - March 8, 2023) -  Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that it is extending the deployment of its CognICA technology with Lions Befrienders Service Association ("Lions Befrienders" or "LBSA"), a leading Singapore-based senior healthcare provider.Established in 1995, Lions Befrienders has addressed the varied needs of...

  2023-03-08 8:30 AM EST
• Cognetivity Neurosciences Announces Commercial Deployment at Leading Psychiatry and Neurology Centre in UAE

  Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that it has reached a commercial agreement with American Center for Psychiatry and Neurology (ACPN) in the United Arab Emirates (UAE).ACPN is a specialist medical facility with branches in the cities of Abu Dhabi, Dubai and...

  2023-02-23 8:30 AM EST
• Cognetivity Announces Further Scientific Evidence of its AI-Powered CognICA(TM) Platform's Ability to Detect and Monitor Cognitive Impairment in Patients With Multiple Sclerosis

  Vancouver, British Columbia--(Newsfile Corp. - February 22, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (FSE: 1UB) (OTCQB: CGNSF) (the "Company" or "Cognetivity") today announced the publication of its latest peer-reviewed scientific paper on its Integrated Cognitive Assessment (ICA) technology in the journal 'Multiple Sclerosis and Related Disorders'. The paper provides further significant evidence of Cognetivity's technology's validity and clinical utility for cognitive assessment in patients with neurological diseases such as multiple sclerosis (MS).The study investigated the link between subjects' performance...

  2023-02-22 8:30 AM EST
• Cognetivity Neurosciences Releases Latest Version of AI-powered Brain Health Assessment Platform

  Vancouver, British Columbia--(Newsfile Corp. - February 14, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that it has released an updated version of its flagship tool, CognICA™.CognICA is a unique platform for the assessment and monitoring of brain health: powered by artificial intelligence (AI), FDA-registered and CE-marked, and commercially...

  2023-02-14 8:30 AM EST
• Cognetivity Neurosciences' CognICA Platform Successfully Monitors Cognitive Performance in Alzheimer's Patients Receiving Disease-Modifying Therapy

  Vancouver, British Columbia--(Newsfile Corp. - January 24, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that its flagship CognICA™ tool has demonstrated effectiveness in tracking cognitive function during the treatment of Alzheimer's disease patients with the disease-modifying therapy Aduhelm™ (aducanumab), manufactured by Biogen.CognICA was used in clinical practice at Mediclinic Parkview...

  2023-01-24 9:00 AM EST
• Cognetivity Neurosciences Provides Update on 2022 Corporate Achievements

  Vancouver, British Columbia--(Newsfile Corp. - January 10, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FWB: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, has provided an update on its corporate achievements during 2022, which position the company for continued, rapid growth in 2023.Key among Cognetivity's 2022 achievements was the strengthening of its collaborative relationships with some of the world's largest pharmaceutical firms. In...

  2023-01-10 9:00 AM EST
• Cognetivity Neurosciences' Brain Health Platform Cited as Case Study as Part of Early Dementia Detection Policy Recommendations by Alzheimer's Research UK

  Vancouver, British Columbia--(Newsfile Corp. - December 13, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, is pleased to announce that the company and its flagship tool, CognICA™, have been cited in a newly published policy paper by the UK's leading dementia research charity, Alzheimer's Research UK.Entitled "Improving dementia diagnosis: what could change in primary care?",...

  2022-12-13 9:00 AM EST
• Cognetivity Neurosciences to Attend HLTH 2022 in Las Vegas and Appoints New Advisory Board Member

  Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) (the "Company" or "Cognetivity"), a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, today announces that it will be attending the HLTH 2022 conference next week. It also announces that it has appointed Dr. Lance Black, MD, MBID, to its advisory board with immediate effect.Taking place this year at The Venetian Expo in...

  2022-11-10 9:00 AM EST